Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2009 3
2010 2
2011 4
2012 4
2013 8
2014 7
2015 4
2016 8
2017 10
2018 7
2019 11
2020 4
2021 17
2022 13
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. Among authors: sorli l. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria.
Pintado V, Ruiz-Garbajosa P, Aguilera-Alonso D, Baquero-Artigao F, Bou G, Cantón R, Grau S, Gutiérrez-Gutiérrez B, Larrosa N, Machuca I, Martínez Martínez L, Montero MM, Morte-Romea E, Oliver A, Paño-Pardo JR, Sorlí L. Pintado V, et al. Among authors: sorli l. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):360-370. doi: 10.1016/j.eimce.2022.06.014. Epub 2022 Dec 13. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 36522272
Ceftolozane-tazobactam: When, how and why using it?
López Montesinos I, Montero M, Sorlí L, Horcajada JP. López Montesinos I, et al. Among authors: sorli l. Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):35-37. doi: 10.37201/req/s01.10.2021. Epub 2021 Sep 30. Rev Esp Quimioter. 2021. PMID: 34598422 Free PMC article. Review.
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review.
Echeverria-Esnal D, Sorli L, Navarrete-Rouco ME, Prim N, Barcelo-Vidal J, Conde-Estévez D, Montero MM, Martin-Ontiyuelo C, Horcajada JP, Grau S. Echeverria-Esnal D, et al. Among authors: sorli l. Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):759-775. doi: 10.1080/14787210.2023.2223977. Epub 2023 Jun 14. Expert Rev Anti Infect Ther. 2023. PMID: 37294450 Review.
[Pharmacokinetics and pharmacodynamics of ceftaroline].
Grau S, Sorlí L, Luque S. Grau S, et al. Among authors: sorli l. Enferm Infecc Microbiol Clin. 2014 Mar;32 Suppl 2:15-20. doi: 10.1016/S0213-005X(14)70153-3. Enferm Infecc Microbiol Clin. 2014. PMID: 24702974 Review. Spanish.
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial.
Sojo-Dorado J, López-Hernández I, Hernández-Torres A, Retamar-Gentil P, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Álvarez RM, Dueñas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jiménez V, Docobo-Pérez F, Pascual Á, Rodríguez-Baño J. Sojo-Dorado J, et al. Among authors: sorli l. J Antimicrob Chemother. 2023 Jul 5;78(7):1658-1666. doi: 10.1093/jac/dkad147. J Antimicrob Chemother. 2023. PMID: 37260299 Free PMC article. Clinical Trial.
[Shedding light on the use of colistin: still gaps to be filled].
Luque S, Grau S, Berenguer N, Horcajada JP, Sorlí L, Montero MM, Salas E. Luque S, et al. Among authors: sorli l. Enferm Infecc Microbiol Clin. 2011 Apr;29(4):287-96. doi: 10.1016/j.eimc.2011.02.003. Enferm Infecc Microbiol Clin. 2011. PMID: 21440335 Review. Spanish.
Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant Pseudomonas aeruginosa.
Sorlí L, Luque S, Li J, Benítez-Cano A, Fernández X, Prim N, Vega V, Gómez-Junyent J, López-Montesinos I, Gómez-Zorrilla S, Montero MM, Grau S, Horcajada JP. Sorlí L, et al. Microbiol Spectr. 2023 Dec 12;11(6):e0296723. doi: 10.1128/spectrum.02967-23. Epub 2023 Nov 9. Microbiol Spectr. 2023. PMID: 37943035 Free PMC article.
Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections.
Fresan D, Luque S, Benítez-Cano A, Sorlí L, Milagro Montero M, De-Antonio M, Prim N, Vega V, Horcajada JP, Grau S. Fresan D, et al. Among authors: sorli l. J Antimicrob Chemother. 2023 Mar 2;78(3):678-683. doi: 10.1093/jac/dkac439. J Antimicrob Chemother. 2023. PMID: 36626402
110 results